MARKET RADAR
SENSEX     NIFTY      Refresh
Ajanta Pharma Yearly Results, Ajanta Pharma Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Yearly Results - Ajanta Pharma
Ajanta Pharma
BSE: 532331|NSE: AJANTPHARM|ISIN: INE031B01031|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 23, 17:00
960.65
-20.1 (-2.05%)
VOLUME 51,333
LIVE
NSE
May 23, 17:00
961.50
-18.75 (-1.91%)
VOLUME 109,804
Download Annual Report PDF Format 2012 | 2011

Yearly Results of Ajanta Pharma

------------------- in Rs. Cr. -------------------
Mar '13 Mar '12 Mar '11 Mar '10 Mar '09
Net Sales/Income from operations 828.50 598.25 457.15 381.67 319.48
Other Operating Income 10.70 6.01 -- -- --
Total Income From Operations 839.20 604.27 457.15 -- --
EXPENDITURE
Consumption of Raw Materials 284.09 230.29 143.20 118.04 96.10
Purchase of Traded Goods 27.35 20.47 -- -- --
Increase/Decrease in Stocks -11.41 -32.99 5.37 16.31 -5.67
Power & Fuel -- -- -- -- --
Employees Cost 115.40 87.17 59.10 50.91 40.46
Depreciation 32.70 30.68 23.79 19.76 13.15
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 216.49 167.39 159.93 125.19 128.85
P/L Before Other Inc. , Int., Excpt. Items & Tax 174.58 101.26 65.76 -- --
Other Income 7.41 1.21 1.65 1.27 1.38
P/L Before Int., Excpt. Items & Tax 181.99 102.47 67.41 -- --
Interest 18.48 22.72 15.66 19.08 22.03
P/L Before Exceptional Items & Tax 163.51 79.75 51.75 33.66 25.94
Exceptional Items -- -- -- -- --
P/L Before Tax 163.51 79.75 51.75 -- --
Tax 62.39 13.26 5.31 5.12 4.56
P/L After Tax from Ordinary Activities 101.12 66.49 46.45 -- --
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 101.12 66.49 46.45 28.54 21.38
Equity Share Capital 11.80 11.80 11.80 11.80 11.80
Reserves Excluding Revaluation Reserves 344.48 260.04 203.75 164.11 104.35
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 43.17 28.39 39.67 -- --
Diluted EPS 43.07 28.39 39.67 -- --
EPS After Extra Ordinary
Basic EPS 43.17 28.39 39.67 -- --
Diluted EPS 43.07 28.39 39.67 -- --
Public Share Holding
No Of Shares (Crores) 0.63 0.35 0.39 0.39 0.39
Share Holding (%) 27.00 29.87 33.18 33.18 33.49
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) 0.11 0.06 0.02 -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) 6.43 6.70 2.56 -- --
- Per. of shares (as a % of the total Share Cap. of the company) 4.70 4.70 1.71 -- --
b) Non-encumbered
- Number of shares (Crores) 1.60 0.77 0.76 -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) 93.57 93.30 97.44 -- --
- Per. of shares (as a % of the total Share Cap. of the company) 68.30 65.43 65.11 -- --
Notes Notes To The Accounts Notes To The Accounts
Source : Dion Global Solutions Limited
Quick Links for ajantapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.